Progress on EU Negotiations

Paul Williams Excerpts

Thursday 22nd November 2018 Commons Chamber

[The Prime Minister]

As I have indicated to a number of Members—obviously I have answered the question about a people’s vote before—I strongly believe that having asked people in this country to determine whether or not this country should remain in the European Union, we, as their elected representatives, should recognise the feeling that was expressed in that vote and should deliver for people on that vote, and that means delivering leaving the European Union.

[Dr Paul Williams (Stockton South) (Lab)]

The problem is that there are no guarantees that things will be as good as they are now. NHS patients get new drugs six months earlier because we are a member of the European Medicines Agency, but the declaration just says that we will “explore the possibility” of future co-operation with the EMA. Would not patients be better off joining my kids writing their wish lists to Santa tonight than relying on this wish list from the Prime Minister?

[The Prime Minister]

There is an assumption in relation to some of these issues, such as our recognition of the role of the European Medicines Agency in the political declaration, that somehow this is only about the UK asking the European Union. Actually, what we are looking at in relation to these matters—the EMA and the European Chemicals Agency, and, indeed, the European Aviation Safety Agency—is, in a number of areas, what is in the mutual interests of both sides, the UK and the European Union. An awful lot of work is done here, in the UK, by our pharmaceutical companies in terms of placing drugs on the European market. There are benefits to both sides of our being able to keep that co-operation in the European Medicines Agency.